Zurueck zur Suche

Reporte zur Charge 040-21A

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

16Reporte angezeigt
0Todesfaelle
3Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MI 3 AZ 2 TN 2 TX 2 AL 1 OK 1 MN 1 CA 1 WA 1

VAERS 1261943

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 04021a

schwer
Staat
AL
Alter
68,0
Geschlecht
M
Eingang
27.04.2021
Impfdatum
23.03.2021
Beginn
23.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dyspnoea Heart rate increased Hunger Syncope

Symptomtext

He was faint; Shortness of breathe; Rapid heart beat; Hungry; This spontaneous case was reported by a consumer and describes the occurrence of SYNCOPE (He was faint) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04021a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced SYNCOPE (He was faint) (seriousness criterion medically significant), DYSPNOEA (Shortness of breathe), HEART RATE INCREASED (Rapid heart beat) and HUNGER (Hungry). At the time of the report, SYNCOPE (He was faint), DYSPNOEA (Shortness of breathe), HEART RATE INCREASED (Rapid heart beat) and HUNGER (Hungry) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications reported were blood pressure medications. No further information regarding names of the medications was provided. No treatment information for the events was reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1095284

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 04021A

schwer
Staat
OK
Alter
51,0
Geschlecht
F
Eingang
12.03.2021
Impfdatum
12.03.2021
Beginn
12.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Anaphylactic reaction Rash

Symptomtext

EPI ADMINISTERED 0.5 ML IM & BENADRYL 50MG IM; TRANSPORTED TO LOCAL HOSPITAL ANAPHYAXIC RASH PRESENTED BY RASH AND GI DISTURBANCE

Weitere VAERSDATA-Felder
Praegender Schweregrund
Anaphylactic reaction
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
STRESS INDUCED STRESS
Andere Medikamente
MIRAPLEX PHENTERMINE NEXIUM IRON FLEXARIL TYLENOL WITH CODEINE
Allergien
MORPHINE VALIUM DILATIN BACTRIM
Vorherige Impfungen
-

VAERS 1644841

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 04021A

moderat
Staat
AZ
Alter
42,0
Geschlecht
M
Eingang
28.08.2021
Impfdatum
31.07.2021
Beginn
31.07.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Dyspnoea Heart rate Heart rate increased Hypersensitivity Pyrexia

Symptomtext

Allergic reaction; Increased Heart Rate; Fever; Shortness of Breath; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HEART RATE INCREASED (Increased Heart Rate), PYREXIA (Fever), DYSPNOEA (Shortness of Breath) and HYPERSENSITIVITY (Allergic reaction) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04021A) for COVID-19 vaccination. No Medical History information was reported. On 31-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jul-2021, the patient experienced HEART RATE INCREASED (Increased Heart Rate) (seriousness criterion hospitalization), PYREXIA (Fever) (seriousness criterion hospitalization) and DYSPNOEA (Shortness of Breath) (seriousness criterion hospitalization). On an unknown date, the patient experienced HYPERSENSITIVITY (Allergic reaction) (seriousness criterion hospitalization). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) for Adverse event, at an unspecified dose and frequency. On 31-Jul-2021, HEART RATE INCREASED (Increased Heart Rate) and DYSPNOEA (Shortness of Breath) had resolved. On 01-Aug-2021, PYREXIA (Fever) had resolved. At the time of the report, HYPERSENSITIVITY (Allergic reaction) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Jul-2021, Heart rate: increased (High) Increased. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not reported. Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
Test Date: 20210731; Test Name: Heart rate; Result Unstructured Data: Increased.
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1518712

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 04021A

moderat
Staat
AZ
Alter
42,0
Geschlecht
M
Eingang
31.07.2021
Impfdatum
01.07.2021
Beginn
31.07.2021
Tage bis Beginn
30,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Dizziness Dyspnoea Ear, nose and throat examination Pharyngeal swelling

Symptomtext

Throat swelling, shortness of breath, light headedness. Occured approximately 15 minutes after shot. Contacted pharmacist, who referred to Emergency Room. Emergency Room Doctor prescribed antihistamine and steroid via IV line. Prescribed Benadryl and Prednisone for 3 days.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
Vital sign monitoring and examination of the throat.
Aktuelle Erkrankungen
None. 15 minutes after vaccination there was throat swelling on the left side. Shortness of breath and light headedness followed.
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2436247

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 04021A

mild
Staat
MN
Alter
44,0
Geschlecht
M
Eingang
09.09.2022
Impfdatum
12.02.2021
Beginn
23.08.2022
Tage bis Beginn
557,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Pyrexia SARS-CoV-2 test positive

Symptomtext

FEVER,

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
2,0
Labordaten
POSITIVE COVID TEST 8/23/22
Aktuelle Erkrankungen
-
Vorgeschichte
? Cerebral palsy (HCC) ? Epilepsy (HCC) ? MR (mental retardation), moderate has bilateral VP shunts ? Nonintractable epilepsy without status epilepticus (HCC) ? Nonintractable epilepsy without status epilepticus, unspecified epilepsy type (HCC) ? S/P VP shunt Recent complication with pseudocyst (10/2016) ? SBO (small bowel obstruction) (HCC) K56.609 ? Leukocytosis D72.829 ? Nonintractable epilepsy without status epilepticus (HCC) G40.909 ? Cerebral palsy, unspecified type (HCC) G80.9 ? Intellectual disability F79 ? Headache, unspecified headache type R51.9 ? Infection of VP (ventriculoperitoneal) shunt (HCC) T85.730A ? Abdominal infection (HCC) K65.9 ? At risk for infection Z91.89 ? S/P VP shunt Z98.2 ? Abdominal pain R10.9 ? Lower abdominal pain R10.30 ? Epilepsy (HCC) G40.909 ? Other constipation K59.09 ? Abscess of abdominal cavity (HCC) K65.1 ? Hypokalemia E87.6 ? Leg pain M79.606 ? Breakthrough seizure (HCC) G40.919 ? Hypocalcemia E83.51 ? Spastic quadriplegic cerebral palsy (HCC) G80.0 ? Vitamin D deficiency, unspecified E55.9 ? Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, without status epilepticus (HCC) G40.009 ? Unspecified esotropia H50.00 ? Strabismic amblyopia, left eye H53.032
Andere Medikamente
? acetaminophen (TYLENOL) 500 mg oral tablet Take 1,000 mg by mouth three times a day. ? bisacodyl (DULCOLAX) 10 mg Rectal Supp suppository Unwrap and insert 1 suppository rectally once a day as needed for Constipation. ? carBAMazepine (T
Allergien
-
Vorherige Impfungen
-

VAERS 2531910

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 04021a

mild
Staat
-
Alter
25,0
Geschlecht
F
Eingang
03.01.2022
Impfdatum
15.04.2021
Beginn
16.04.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site swelling Peripheral swelling

Symptomtext

swelling at injection site Narrative: Per supervisor report: " stated right arm swollen after second immunization. ... She further stated that she was out four days with the first injection after having a fever."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site swelling
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1606460

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 04021A

mild
Staat
CA
Alter
69,0
Geschlecht
M
Eingang
22.08.2021
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blood urine present Diarrhoea

Symptomtext

diarrhea; blood in urine; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) and BLOOD URINE PRESENT (blood in urine) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04021A) for COVID-19 immunization. Concurrent medical conditions included Prostatic disorder and Cholesterol. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhea) and BLOOD URINE PRESENT (blood in urine). At the time of the report, DIARRHOEA (diarrhea) and BLOOD URINE PRESENT (blood in urine) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment was reported. Concomitant medications were reported for prostate and cholesterol but not specified. Patient wanted to know if he should get second dose tomorrow given the symptoms and prostate treatment.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Diarrhoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Cholesterol; Prostatic disorder
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1606060

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 04021A

mild
Staat
TN
Alter
59,0
Geschlecht
F
Eingang
22.08.2021
Impfdatum
26.03.2021
Beginn
07.04.2021
Tage bis Beginn
12,0
Dosis
1
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pruritus Skin reaction

Symptomtext

delayed reaction to vaccine; itching at the injection site; redness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of SKIN REACTION (delayed reaction to vaccine), INJECTION SITE PRURITUS (itching at the injection site) and INJECTION SITE ERYTHEMA (redness at the injection site) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04021A) for COVID-19 vaccination. The patient's past medical history included Asthma. On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 07-Apr-2021, the patient experienced SKIN REACTION (delayed reaction to vaccine), INJECTION SITE PRURITUS (itching at the injection site) and INJECTION SITE ERYTHEMA (redness at the injection site). The patient was treated with CORTISONE at an unspecified dose and frequency. At the time of the report, SKIN REACTION (delayed reaction to vaccine), INJECTION SITE PRURITUS (itching at the injection site) and INJECTION SITE ERYTHEMA (redness at the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Asthma
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1601721

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 04021A

mild
Staat
MI
Alter
72,0
Geschlecht
F
Eingang
21.08.2021
Impfdatum
20.03.2021
Beginn
20.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Body temperature Chills Fatigue Headache Myalgia Pyrexia

Symptomtext

on the second day after vaccine patient had a headache for the day; fatigue; muscle pain; chills; fever of 101.1 degrees F; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), MYALGIA (muscle pain), CHILLS (chills), PYREXIA (fever of 101.1 degrees F) and HEADACHE (on the second day after vaccine patient had a headache for the day) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04021A) for COVID-19 vaccination. Concomitant products included METOPROLOL, DULOXETINE and OLANZAPINE for an unknown indication. On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On 20-Mar-2021, the patient experienced FATIGUE (fatigue), MYALGIA (muscle pain), CHILLS (chills) and PYREXIA (fever of 101.1 degrees F). On 21-Mar-2021, the patient experienced HEADACHE (on the second day after vaccine patient had a headache for the day). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 21-Mar-2021, FATIGUE (fatigue) and HEADACHE (on the second day after vaccine patient had a headache for the day) had resolved. On 22-Mar-2021, MYALGIA (muscle pain), CHILLS (chills) and PYREXIA (fever of 101.1 degrees F) had resolved. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Mar-2021, Body temperature: elevated (High) 101.1. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient has scheduled 2nd dose of vaccine on17-04-2021. Patient reports taking an over the counter Migraine Pill (NOS) that contained caffeine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
Test Date: 20210320; Test Name: Body temperature; Result Unstructured Data: 101.1
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
METOPROLOL; DULOXETINE; OLANZAPINE
Allergien
-
Vorherige Impfungen
-

VAERS 1566592

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 040-21A

mild
Staat
-
Alter
56,0
Geschlecht
F
Eingang
15.08.2021
Impfdatum
12.03.2021
Beginn
12.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dysgeusia Hypoaesthesia oral Pain in extremity

Symptomtext

Metallic taste in the mouth; Tongue went numb; Sore arm; This spontaneous case was reported by a patient and describes the occurrence of DYSGEUSIA (Metallic taste in the mouth), HYPOAESTHESIA ORAL (Tongue went numb) and PAIN IN EXTREMITY (Sore arm) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040-21A) for COVID-19 vaccination. No Medical History information was reported. On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced DYSGEUSIA (Metallic taste in the mouth), HYPOAESTHESIA ORAL (Tongue went numb) and PAIN IN EXTREMITY (Sore arm). At the time of the report, DYSGEUSIA (Metallic taste in the mouth) outcome was unknown and HYPOAESTHESIA ORAL (Tongue went numb) and PAIN IN EXTREMITY (Sore arm) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. Treatment information was not provided. Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: Patient provided email address and wanted to have details of her second shot when she received it, for documentation purposes. On 22-May-2021: The patient stated that she had not experienced nausea

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1536347

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 04021A

mild
Staat
TX
Alter
58,0
Geschlecht
F
Eingang
09.08.2021
Impfdatum
15.03.2021
Beginn
15.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inflammation Pain

Symptomtext

Entire body inflamed, could not move with out intense pain for about 36 hours

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1204511

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 04021A

mild
Staat
TN
Alter
39,0
Geschlecht
F
Eingang
13.04.2021
Impfdatum
29.03.2021
Beginn
06.04.2021
Tage bis Beginn
8,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Back pain Fatigue Impaired work ability Injection site erythema Injection site induration Injection site swelling Injection site warmth Pain in extremity Rash

Symptomtext

Sore arm the first night. 8 days in I got what I believe is COVID arm. The injection site was warm, red, swollen, and felt like a big knot or lump. Fatigue, back pain. On day 13 I also got a rash on the inside of my arm, on the bicep area. It was red, bumpy, and slightly itchy. I missed some work due to fatigue.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Back pain
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
BMI over 30 "obesity"
Andere Medikamente
birth control
Allergien
none
Vorherige Impfungen
-

VAERS 1099209

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 04021A

mild
Staat
WA
Alter
35,0
Geschlecht
F
Eingang
14.03.2021
Impfdatum
13.03.2021
Beginn
13.03.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Dizziness

Symptomtext

P c/o dizziness. Juice PO administered. Pt improved p 5-10 min. Released w/o interventions. BP & HR wnl. Pt required no primary medical help.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2593216

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 04021A

gering
Staat
MI
Alter
55,0
Geschlecht
F
Eingang
08.03.2023
Impfdatum
05.05.2021
Beginn
07.01.2022
Tage bis Beginn
247,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 2 vaccines Moderna 4/7/21 Lot# 017B21A; Moderna 5/5/21 Lot# 040b21A

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
COVID +
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1744385

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 04021A

gering
Staat
TX
Alter
46,0
Geschlecht
F
Eingang
29.09.2021
Impfdatum
14.04.2021
Beginn
27.07.2021
Tage bis Beginn
104,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Intermenstrual bleeding Menstruation irregular

Symptomtext

Menstrual cycle started 4-5 days early (07-28-2021-day1). Cycle was unusually heavy and lasted until 08-07-2021( 12 days). Normal cycle lasts 5-6 days and begins around day 26/27. Missed next two cycles. Light spotting on 09-29-2021 is first since 08-07-2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intermenstrual bleeding
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Bupropion XL 300mg x 1/day Adderall XR 30mg x 1/day Biotin Keratin Vitamin D
Allergien
Sulfa sensitive
Vorherige Impfungen
-

VAERS 1278049

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 04021A

gering
Staat
MI
Alter
62,0
Geschlecht
M
Eingang
01.05.2021
Impfdatum
07.04.2021
Beginn
08.04.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Herpes zoster

Symptomtext

patient developed shingles

Weitere VAERSDATA-Felder
Praegender Schweregrund
Herpes zoster
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
NONE
Vorherige Impfungen
-